Elizabeth A Eckman

Title: Elizabeth A Eckman: Innovator in Alzheimer's Research

Introduction

Elizabeth A Eckman is a prominent inventor based in Ponte Vedra Beach, FL (US). She has made significant contributions to the field of Alzheimer's disease research through her innovative work. Her dedication to understanding and treating this complex condition has led to the development of valuable patents.

Latest Patents

Elizabeth A Eckman holds a patent related to "Endothelin converting enzymes and the amyloid β peptide." This invention describes the catabolism of Aβ by endothelin converting enzymes (ECEs). The patent provides methods for identifying compounds that upregulate ECEs, as well as methods for regulating Aβ catabolism in a cell. Additionally, it outlines techniques for decreasing the amount of Aβ in a cell. The invention also includes methods for diagnosing individuals with Alzheimer's disease and treating them effectively. Furthermore, it discloses methods for identifying compounds that possess anti-hypertension activity without increasing Aβ levels. The patent also provides mutant ECE nucleic acids and mutant ECE polypeptides.

Career Highlights

Elizabeth A Eckman is associated with the Mayo Foundation for Medical Education and Research, where she continues her impactful work in medical research. Her career is marked by a commitment to advancing the understanding of Alzheimer's disease and developing innovative solutions to combat it.

Collaborations

Elizabeth collaborates with Christopher B Eckman, further enhancing her research efforts and contributions to the field.

Conclusion

Elizabeth A Eckman is a key figure in Alzheimer's research, with her innovative patent addressing critical aspects of the disease. Her work continues to inspire advancements in medical science and treatment options.